GlassScriptPhysician profile
Roderick Peter Diggs
NPI 1720099013
$4,749.35
in general payments reported to CMS, 2019-2025
32 companies · $982 in 2025
The $982 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $622 · 2020: $115 · 2021: $609 · 2022: $762 · 2023: $766 · 2024: $894 · 2025: $982.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,562 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,561.60 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Okami Medical, INC. | $845.41 | 2024-2025 | Lobo |
| Abiomed | $787.33 | 2019-2021 | |
| Inari Medical, INC. | $538.15 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbvie INC. | $350.37 | 2019-2023 | Orilissa |
| Myriad Women'S Health, INC. | $292.02 | 2023 | Myrisk |
| Sumitomo Pharma America, INC. | $246.67 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $230.67 | 2023-2025 | Veozah |
| Myovant Sciences INC. | $195.47 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $170.53 | 2019-2025 | |
| Amgen INC. | $121.86 | 2025 | Repatha |
| Glaxosmithkline, LLC. | $121.86 | 2023 | Arexvy |
| Exeltis, USA INC. | $117.15 | 2022-2025 | Slynd |
| Organon LLC | $96.28 | 2021-2025 | Nexplanon |
| Therapeuticsmd, INC. | $66.80 | 2021-2022 | |
| Applied Medical Resources Corporation | $62.09 | 2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $60.17 | 2022 | |
| Hologic Sales and Service, LLC | $58.74 | 2020-2022 | |
| Biogen, INC. | $51.97 | 2024-2025 | Zurzuvae |
| Kci USA, INC. | $41.19 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $36.82 | 2019-2020 | |
| Optumhealth Care Solutions, LLC | $36.02 | 2023-2024 | Vivify Health Care Team Portal 001, Eitan Medical, Zyno Solutions |
| Mayne Pharma Commercial LLC | $33.77 | 2024 | |
| Pfizer INC. | $28.08 | 2024 | |
| Solventum Corporation | $27.36 | 2024 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Evofem Biosciences, INC. | $23.83 | 2022 | |
| Lupin INC. | $21.41 | 2019 | |
| Amag Pharmaceuticals, INC. | $17.05 | 2019 | |
| Millicent US INC | $16.91 | 2019 | |
| Exact Sciences Corporation | $15.08 | 2024 | Cologuard Collection Kit |
| Aspira Women'S Health INC | $14.95 | 2024 | Ova1 |
| Endo Pharmaceuticals INC. | $11.92 | 2020 | |
| Mission Pharmacal Company | $11.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roderick Diggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.